AROMATIC FUNCTIONALLY SUBSTITUTED IMINES AND HYDRAZIDES–MYELOPEROXIDASE INHIBITORS

Polina Shishkanova1, Darya Sharshunovich1, Galina Semenkova1, Victor Sorokin1, Oleg Shadyro1

1 Department of Radiation Chemistry and Chemical-Pharmaceutical Technology, Belarusian State University, Minsk

Myeloperoxidase (MPO, EC 1.11.1.7) can be found in the azurophil granules of neutrophils, in monocytes and also in certain types of tissue macrophages. Generated by this enzyme reactive oxidants (HOCl, reactive oxygen species (ROS)) are involved in the microbicidal activity of neutrophils, contributing to innate host defenses. After the activation of phagocytes there is degranulation and MPO is secreted either inside the phagosome or to extracellular space [1]. Increased level of MPO in neutrophils and in blood may be accompanied by the hyperproduction of HOCl, which leads to the development of halogenating stress in the organism. This may become the cause to cardiovascular disease [2]. It is shown that an increasing level of the MPO in the blood increases the risk of myocardial infarction and sudden death of patients with chest pain and acute coronary syndrome. In the literature there are data that in the organism there are compounds that affect the output of hypochlorous acid, reducing its quantity(taurine) or inhibit the enzyme activity (ceruloplasmin) [5]. However, in the area of inflammation these endogenous compounds may not be in such quantity to prevent halogenating stress. In this case, you must use compounds aimed at reducing MPO activity. At the same time the ability of neutrophils to phagocytosis should be maintained. In this regard, is urgent to develop new approaches aimed at preventing the occurrence of halogenating stress in the organism.

The purpose of this study is to create new effective MPO inhibitors based on aromatic functionally substituted imines and hydrazides.

Neutrophils were allocated from blood of healthy people on the basis of a standard method. Cells were destroyed in three cycles of freezing and thawing. The resulting mixture was centrifuged. The supernatant containing free MPO was used for the analysis. The enzyme activity was determined by its ability to generate HOCl and ROS in peroxidase and halogenating cycles at pH 7.4 and 5.2 respectively. The formation of ROS and HOCl were registered by chemiluminescent method at the temperature of 37°C in Earl's solution, containing H2O2 and luminol. Measurements were conducted with using biochemiluminometer BHL-1 (BSU, Belarus).

We synthesized following compounds, which are derivations from aromatic functionally substituted imines and hydrazides: 4,6-di-tert-butyl-3-(((2-mercaptophenyl)imino)methyl)benzene-1,2-diol, 4,6-di-tert-butyl-3-(((2-mercaptoethyl)imino)methyl)benzene-1,2-diol, 4,6-di-tert-butyl-3-((2-phenylhydrazineylidene)methyl)benzene-1,2-diol, N'-(2,3-dihydroxybenzylidene)isonicotinohydrazide, 2-hydroxybenzohydrazide.

It was found that in the system «MPO - luminol - H2O2» at pH=5.2 degree of inhibition of halogenating activity of MPO in the presence of analyted substances in concentrations 4·10-6 mol/l decreases from 96±3,9 to 29±5,5% in the following sequence: 4,6-di-tert-butyl-3-((2-phenylhydrazineylidene)methyl)benzene-1,2-diol > N'-(2,3-dihydroxybenzylidene)isonicotinohydrazide ≈ 4,6-di-tert-butyl-3-(((2-mercaptophenyl)imino)methyl)benzene-1,2-diol > 4,6-di-tert-butyl-3-(((2-mercaptoethyl)imino)methyl)benzene-1,2-diol > 2-hydroxybenzohydrazide.

The degree of inhibition of peroxidase activity of MPO (pH=7.4) in the presence of these compounds in a concentration 4·10-6 mol/l decreases from 83±2,8 to 40±4,9% as follows: 4,6-di-tert-butyl-3-(((2-mercaptophenyl)imino)methyl)benzene-1,2-diol ≈ 4,6-di-tert-butyl-3-((2-phenylhydrazineylidene)methyl)benzene-1,2-diol > 4,6-di-tert-butyl-3-(((2-mercaptoethyl)imino)methyl)benzene-1,2-diol ≈ N'-(2,3-dihydroxybenzylidene)isonicotinohydrazide ≈ 2-hydroxybenzohydrazide.

These compounds do not have significant impact on the output of active products in the reactions of oxidation of luminol by hydrogen peroxide or HOCl.

Thus, the proposed substances, effectively inhibiting the formation of ROS and HOCl by myeloperoxidase, can be considered as potential medicine compounds for the prevention of halogenating and oxidative stress in the organism.


[1] Klebanoff S.J. // J. Leukoc. Biol. - 2005 - V. 77. P. 598.

[2] Zhang R., Brennan M.L., Fu X. // JAMA. - 2001 - V. 286. P. 2136.

[3] Baldus S., Heeschen C. et al // Circulation. - 2003 - V. 108. P. 1440.

[4] Brennan M.L., Penn M.S., Van Lente F. // N Engl J Med. - 2003 - V. 349. P. 1595.

[5] A.V. Sokolov, K.V. Ageeva et al // Chem. Phys. Lipids. – 2010. – V. 163. – P. 347–355.